Your browser doesn't support javascript.
loading
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
Pils, Dietmar; Bachmayr-Heyda, Anna; Auer, Katharina; Svoboda, Martin; Auner, Veronika; Hager, Gudrun; Obermayr, Eva; Reiner, Angelika; Reinthaller, Alexander; Speiser, Paul; Braicu, Ioana; Sehouli, Jalid; Lambrechts, Sandrina; Vergote, Ignace; Mahner, Sven; Berger, Astrid; Cacsire Castillo-Tong, Dan; Zeillinger, Robert.
Afiliación
  • Pils D; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria. Electronic address: dietmar.pils@univie.ac.at.
  • Bachmayr-Heyda A; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Auer K; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Svoboda M; Department of Pathophysiology and Allergy Research, Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Auner V; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Hager G; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Obermayr E; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster "Translational Oncology", General Hospital Vienna, Vienna, Austria.
  • Reiner A; Institute for Pathology, Danube Hospital, Vienna, Austria.
  • Reinthaller A; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Speiser P; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Braicu I; Department of Gynecology, Campus Virchow Klinikum, Charité Medical University, Berlin, Germany.
  • Sehouli J; Department of Gynecology, Campus Virchow Klinikum, Charité Medical University, Berlin, Germany.
  • Lambrechts S; Department of Obstetrics and Gynecology, Division of Gynecological Oncology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Vergote I; Department of Obstetrics and Gynecology, Division of Gynecological Oncology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Mahner S; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, MUMC+, GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands.
  • Berger A; Department of Gynecology and Obstetrics, Medical University Innsbruck, Innsbruck, Austria.
  • Cacsire Castillo-Tong D; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
  • Zeillinger R; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster "Translational Oncology", General Hospital Vienna, Vienna, Austria.
Eur J Cancer ; 50(1): 99-110, 2014 Jan.
Article en En | MEDLINE | ID: mdl-24176298

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Proteínas Oncogénicas / Neoplasias Glandulares y Epiteliales / Ciclina E Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Biomarcadores de Tumor / Proteínas Oncogénicas / Neoplasias Glandulares y Epiteliales / Ciclina E Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido